参考文献/References:
[1] Jain N,Reilly RF.Hungry bone syndrome[J].Curr Opin Nephrol Hypertens,2017,26(4):250-255.DOI:10.1097/MNH.0000000000000327.
[2] Kaderli RM,Riss P,Geroldinger A,et al.Primary hyperparathyroidism:dynamic postoperative metabolic changes[J].Clin Endocrinol(Oxf),2018,88(1):129-138.DOI:10.1111/cen.13476.
[3] Sharanappa V,Mishra A,Bhatia V,et al.Pediatric primary hyperparathyroidism:experience in a tertiary care referral center in a developing country over three decades[J].World J Surg,2021,45(2):488-495.DOI:10.1007/s00268-020-05816-4.
[4] Wen P,Xu L,Zhao S,et al.Risk factors for severe hypocalcemia in patients with secondary hyperparathyroidism after total parathyroidectomy[J].Int J Endocrinol,2021,2021:6613659.DOI:10.1155/2021/6613659.
[5] Honda M,Shimata K,Sambommatsu Y,et al.Hungry bone syndrome after living donor liver transplant for biliary atresia[J].Exp Clin Transplant,2021,19(4):386-389.DOI:10.6002/ect.2020.0413.
[6] Press D,Politz D,Lopez J,et al.The effect of vitamin D levels on postoperative calcium requirements,symptomatic hypocalcemia,and parathormone levels following parathyroidectomy for primary hyperparathyroidism[J].Surgery,2011,150(6):1061-1068.DOI:10.1016/j.surg.2011.09.018.
[7] Gao D,Lou Y,Cui Y,et al.Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy:a meta-analysis[J].Ren Fail,2022,44(1):503-512.DOI:10.1080/0886022X.2022.2048856.
[8] Kritmetapak K,Kongpetch S,Chotmongkol W,et al.Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism[J].Ren Fail,2020,42(1):1118-1126.DOI:10.1080/0886022X.2020.1841655.
[9] Kaderli RM,Riss P,Dunkler D,et al.The impact of vitamin D status on hungry bone syndrome after surgery for primary hyperparathyroidism[J].Eur J Endocrinol,2018,178(1):1-9.DOI:10.1530/EJE-17-0416.
[10] Salman MA,Rabiee A,Salman AA,et al.Role of vitamin D supplements in prevention of hungry bone syndrome after successful parathyroidectomy for primary hyperparathyroidism:a prospective study[J].Scand J Surg,2021,110(3):329-334.DOI:10.1177/1457496920962601.
[11] Choudhary S,Santone E,Yee SP,et al.Continuous PTH in male mice causes bone loss because It induces serum amyloid A[J].Endocrinology,2018,159(7):2759-2776.DOI:10.1210/en.2018-00265.
[12] Liu S,Zhu W,Li S,et al.The effect of bovine parathyroid hormone withdrawal on MC3T3-E1 cell proliferation and phosphorus metabolism[J].PLoS One,2015,10(3):e0120402.DOI:10.1371/journal.pone.0120402.
[13] Jakubauskas M,Beisˇa V,Strupas K.Risk factors of developing the hungry bone syndrome after parathyroidectomy for primary hyperparathyroidism[J].Acta Med Litu,2018,25(1):45-51.DOI:10.6001/actamedica.v25i1.3703.
[14] Liu C,Tang L,Goel P,et al.A practical mathematic method to predict and manage hypocalcemia after parathyroidectomy and thyroidectomy[J].Ann Otol Rhinol Laryngol,2020,129(1):70-77.DOI:10.1177/0003489419876291.
[15] Ge Y,Yang G,Wang N,et al.Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism[J].Int Urol Nephrol,2019,51(8):1443-1449.DOI:10.1007/s11255-019-02217-y.
[16] Sun L,He X,Liu T.Preoperative serum alkaline phosphatase:a predictive factor for early hypocalcaemia following parathyroidectomy of primary hyperparathyroidism[J].Chin Med J(Engl),2014,127(18):3259-3264.
[17] Zou Y,Zhang N,Tang Y,et al.Predictive markers for severe hypocalcemia in dialysis patients with secondary hyperparathyroidism after near-total parathyroidectomy[J].Ann Palliat Med,2021,10(10):10712-10719.DOI:10.21037/apm-21-2509.
[18] Ko WC,Liu CL,Lee JJ,et al.Osteocalcin is an independent predictor for hungry bone syndrome after parathyroidectomy[J].World J Surg,2020,44(3):795-802.DOI:10.1007/s00268-019-05251-0.
[19] Paepegaey AC,Velayoudom FL,Housni S,et al.A hungry bone syndrome predicted by 18F-Fluorocholine PET/CT[J].Clin Nucl Med,2019,44(11):903-904.DOI:10.1097/RLU.0000000000002676.
[20] Guillén Martínez AJ,Smilg Nicolás C,Moraleda Deleito J,et al.Risk factors and evolution of calcium and parathyroid hormone levels in hungry bone syndrome after parthyroidectomy for primary hyperparathyroidism[J].Endocrinol Diabetes Nutr(Engl Ed),2020,67(5):310-316.DOI:10.1016/j.endinu.2019.05.011.
[21] Williams-Karnesky RL,Krumeich L,Wachtel H,et al.Data to inform counseling on parathyroidectomy for secondary hyperparathyroidism of renal origin[J].Surgery,2022,171(1):63-68.DOI:10.1016/j.surg.2021.08.009.
[22] Ho LY,Wong PN,Sin HK,et al.Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism[J].BMC Nephrol,2017,18(1):12.DOI:10.1186/s12882-016-0421-5.
[23] Wang M,Chen B,Zou X,et al.A nomogram to predict hungry bone syndrome after parathyroidectomy in patients with secondary hyperparathyroidism[J].J Surg Res,2020,255:33-41.DOI:10.1016/j.jss.2020.05.036.
[24] Sun X,Zhang X,Lu Y,et al.Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism[J].Sci Rep,2018,8(1):7743.DOI:10.1038/s41598-018-26142-9.
[25] Ge P,Liu S,Sheng X,et al.Serum parathyroid hormone and alkaline phosphatase as predictors of calcium requirements after total parathyroidectomy for hypocalcemia in secondary hyperparathyroidism[J].Head Neck,2018,40(2):324-329.DOI:10.1002/hed.24965.
[26] Wong J,Fu WH,Lim ELA,et al.Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients:review of an alkaline phosphatase-based treatment protocol[J].Int Urol Nephrol,2020,52(3):557-564.DOI:10.1007/s11255-020-02387-0.
[27] Mayilvaganan S,Vijaya Sarathi HA,Shivaprasad C.Preoperative zoledronic acid therapy prevent hungry bone syndrome in patients with primary hyperparathyroidism[J].Indian J Endocrinol Metab,2017,21(1):76-79.DOI:10.4103/2230-8210.196023.
[28] 孔令泉,伍娟,田申,等.关注甲状腺癌术后骨饥饿综合征及甲状旁腺功能增强或亢进的防治 [J].中华内分泌外科杂志,2022,16(1):1-4.DOI:10.3760/cma.j.cn.115807-20211222-00395.
[29] Ahmed C,Kendi F,Gebran N,et al.Use of recombinant Human parathyroid hormone to treat hungry bone syndrome in hemodialysis patient[J].Oman Med J,2020,35(4):e164.DOI:10.5001/omj.2020.106.